Product Information

GABAPENTIN 100 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0209 per EA under NDC 31722014805. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on May 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 100 MG CAPSULE

gabapentin
$0.0209per EA
High Outlier

Strength

100 mg/1

NDC

31722014805

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214956

FDA Approved

5/10/2021

TE Code

AB

On Market Since

5/10/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 100 MG CAPSULE has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0276 (Dec 13, 2023)
All-time low$0.0186 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0208
Median price$0.0223
Average price$0.0227
Largest weekly change-19.1% (Nov 20, 2024)
Weeks tracked146
Tracking sinceNov 8, 2023

Price History

1W

+1.0%

1M

-0.1%

3M

-1.0%

6M

-1.4%

1Y

-5.1%

3Y

N/A

5Y

N/A

All

-15.1%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0209 per EA (NDC 31722014805), effective Aug 19, 2026.

How has the price of GABAPENTIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 15.1%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?

Since Nov 8, 2023, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0186 (Nov 20, 2024) to a high of $0.0276 (Dec 13, 2023), with a median of $0.0223 per EA.

Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 100 MG CAPSULE?

GABAPENTIN 100 MG CAPSULE (NDC 31722014805) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.